• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过单采获得的少量血浆制备冻干热处理冷沉淀。

Preparation of lyophilized heat-treated cryoprecipitates from a small pool of plasma obtained by apheresis.

作者信息

Allersma D P, Roeffen E, Van der Does J A, Briët E

机构信息

Central Pharmacy of the Hospitals of The Hague, The Netherlands.

出版信息

Pharm Weekbl Sci. 1991 Feb 22;13(1):18-23. doi: 10.1007/BF01963879.

DOI:10.1007/BF01963879
PMID:1903526
Abstract

A method was developed for the batch-wise production of small-pool lyophilized heat-treated cryoprecipitates in a regional Blood Bank. Ten vials of final product were derived from twenty 600 g apheresis plasma donations. We found 384 IU of factor VIII per vial and a specific activity of 0.20 IU per mg total protein. Production recovery was 340 IU of factor VIII per kg plasma. The method was easy to perform and gave a product of good quality.

摘要

在一家地区血库中开发了一种用于批量生产小池冻干热处理冷沉淀的方法。最终产品的十瓶来自二十份600克单采血浆捐献。我们发现每瓶中有384国际单位的凝血因子VIII,总蛋白的比活性为每毫克0.20国际单位。生产回收率为每千克血浆340国际单位的凝血因子VIII。该方法易于操作,且产品质量良好。

相似文献

1
Preparation of lyophilized heat-treated cryoprecipitates from a small pool of plasma obtained by apheresis.通过单采获得的少量血浆制备冻干热处理冷沉淀。
Pharm Weekbl Sci. 1991 Feb 22;13(1):18-23. doi: 10.1007/BF01963879.
2
Quality control programme for the preparation of small-pool lyophilized heat-treated cryoprecipitates.
Pharm Weekbl Sci. 1991 Feb 22;13(1):24-31. doi: 10.1007/BF01963880.
3
Development and small-scale production of a severely heated factor VIII concentrate.一种经过深度加热的凝血因子VIII浓缩物的研发与小规模生产。
Vox Sang. 1994;66(2):89-95. doi: 10.1111/j.1423-0410.1994.tb00288.x.
4
Development of a heat-treated factor VIII/von Willebrand factor concentrate prepared from heparinized plasma.由肝素化血浆制备的热处理凝血因子VIII/血管性血友病因子浓缩物的研发。
Thromb Haemost. 1990 Jun 28;63(3):392-402.
5
Factor VIII and fibrinogen recovery in plasma after Theraflex methylene blue-treatment: effect of plasma source and treatment time.Theraflex亚甲蓝处理后血浆中凝血因子VIII和纤维蛋白原的回收率:血浆来源和处理时间的影响
Blood Transfus. 2014 Apr;12(2):226-31. doi: 10.2450/2014.0176-13.
6
[Factor VIII:C activity during heat inactivation of viruses in cryoprecipitates].[冷沉淀中病毒热灭活过程中的凝血因子 VIII:C 活性]
Lijec Vjesn. 1990 Jul-Aug;112(7-8):212-5.
7
A heat-treated factor VIII concentrate prepared by controlled-pore glass adsorption chromatography.一种通过可控孔径玻璃吸附色谱法制备的热处理凝血因子VIII浓缩剂。
Transfusion. 1987 Mar-Apr;27(2):174-7. doi: 10.1046/j.1537-2995.1987.27287150194.x.
8
Influence of heat treatment on FVIII:C recovery from freeze dried cryoprecipitate.热处理对冻干冷沉淀中FVIII:C回收率的影响。
J Clin Pathol. 1988 Sep;41(9):945-7. doi: 10.1136/jcp.41.9.945.
9
Double cryoprecipitated factor VIII concentrate from heparinised plasma and its heat treatment.
Blut. 1988 Mar;56(3):111-6. doi: 10.1007/BF00320015.
10
A simple plasma anticoagulant-exchange method to increase the recovery of factor VIII in therapeutic concentrates.一种用于提高治疗性浓缩物中凝血因子 VIII 回收率的简单血浆抗凝剂交换方法。
Vox Sang. 1990;58(4):264-9. doi: 10.1111/j.1423-0410.1990.tb04997.x.

引用本文的文献

1
Quality control programme for the preparation of small-pool lyophilized heat-treated cryoprecipitates.
Pharm Weekbl Sci. 1991 Feb 22;13(1):24-31. doi: 10.1007/BF01963880.

本文引用的文献

1
Determination of serum proteins by means of the biuret reaction.通过双缩脲反应测定血清蛋白。
J Biol Chem. 1949 Feb;177(2):751-66.
2
A process for preparation of 'high-purity' factor VIII by controlled pore glass treatment.一种通过可控孔径玻璃处理制备“高纯度”凝血因子 VIII 的方法。
Vox Sang. 1984;46(6):341-8. doi: 10.1111/j.1423-0410.1984.tb00097.x.
3
Stabilising effect of aminoacids on factor VIII in lyophilised cryoprecipitate.氨基酸对冻干冷沉淀中凝血因子 VIII 的稳定作用。
Lancet. 1984 Dec 8;2(8415):1345. doi: 10.1016/s0140-6736(84)90858-4.
4
Plasma separation using a hollow fiber membrane device.使用中空纤维膜装置进行血浆分离。
Transfusion. 1986 Mar-Apr;26(2):145-50. doi: 10.1046/j.1537-2995.1986.26286152903.x.
5
Technical aspects of different donor plasmapheresis systems and biological results obtained in collected plasma.不同供体血浆置换系统的技术方面以及采集血浆中获得的生物学结果。
Vox Sang. 1986;51 Suppl 1:40-4. doi: 10.1111/j.1423-0410.1986.tb01993.x.
6
Plasma collection using an automated membrane device.使用自动化膜装置采集血浆。
Transfusion. 1986 May-Jun;26(3):269-71. doi: 10.1046/j.1537-2995.1986.26386209385.x.
7
Thermal inactivation of human immunodeficiency virus in lyophilised blood products evaluated by ID50 titrations.通过半数感染剂量(ID50)滴定法评估冻干血液制品中人类免疫缺陷病毒的热灭活情况。
Vox Sang. 1986;51(3):239-43. doi: 10.1111/j.1423-0410.1986.tb01962.x.
8
Heat sterilisation to inactivate AIDS virus in lyophilised factor VIII.热灭菌以灭活冻干的凝血因子 VIII 中的艾滋病病毒。
Aust N Z J Med. 1986 Jun;16(3):413. doi: 10.1111/j.1445-5994.1986.tb01203.x.
9
Preparation of stable lyophilized cryoprecipitate in the original frozen plasma bags.在原始冷冻血浆袋中制备稳定的冻干冷沉淀。
Vox Sang. 1986;50(1):38-41. doi: 10.1111/j.1423-0410.1986.tb04843.x.
10
Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor.获得性免疫缺陷综合征病毒(人类嗜T淋巴细胞病毒III型/淋巴结病相关病毒)的热灭活,特别涉及抗血友病因子
J Clin Invest. 1985 Aug;76(2):875-7. doi: 10.1172/JCI112045.